L-arginine levels in blood as a marker of nitric oxide-mediated brain damage in acute stroke:: A clinical and experimental study

被引:38
作者
Armengou, A
Hurtado, T
Leira, T
Obón, M
Pascual, C
Moro, MA
Lizasoain, I
Castillo, J
Dávalos, A
机构
[1] Hosp Univ Doctor Josep Trueta, Dept Neurol, E-17007 Girona, Spain
[2] Hosp Univ Doctor Josep Trueta, Dept Biochem, Girona, Spain
[3] Hosp Clin Univ Santiago, Dept Neurol, Santiago De Compostela, Spain
[4] Univ Complutense Madrid, Fac Med, Dept Pharmacol, E-28040 Madrid, Spain
关键词
L-arginine; nitric oxide; cerebral infarct; rats; iNOS; 1400W; neuroprotection;
D O I
10.1097/01.WCB.0000080651.64357.C6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There are no useful markers in blood of nitric oxide (NO)-mediated brain damage. Because L-arginine (L-arg) is the only known substrate for NO generation, the authors investigated the plasma profile Of L-arg after cerebral ischemia, and the relationship of L-arg concentrations in blood with stroke outcome and infarct volume in a clinical and experimental study. L-Arg levels were determined with high-performance liquid chromatography in blood and CSF samples obtained on admission, and in blood 48 hours after inclusion, in 268 patients admitted with a hemispheric ischemic stroke lasting 8.2 +/- 5.9 hours. Infarct volume was measured by days 4 to 7 using computed tomography. Plasma L-arg profiles were analyzed in a separate group of 29 patients seen within 8 hours of onset (median, 4.5 hours) and in 24 male Fischer rats treated with subcutaneous vehicle or 20-mg/kg 1400W (a specific inducible NO synthase inhibitor) every 8 hours for 3 days after performing sham or permanent middle cerebral artery occlusion. Plasma L-arg concentrations decreased after the ischemic event, both in patients and rats, and peaked between 6 and 24 hours. In patients, there was a highly correlation between L-arg levels in CSF and plasma at 48 hours (r = 0.85, P<0.001). CSF and plasma L-arg concentrations negatively correlated with infarct volume (r = -0.40 and r = -0.35, respectively, P<0.001), and were significantly lower in patients with early neurologic deterioration and in those with poor outcome (Barthel index <85) at 90 days (P<0.001). In rats, the administration of 1400W resulted in a 55% significant reduction of infarct volume measured 72 hours after permanent middle cerebral artery occlusion, an effect that correlated with the inhibition caused by 1400W on the ischemia-induced decrease of plasma L-arg concentrations at 6 to 24 hours after the onset of the ischemia. Taken together, these data indicate that determination Of L-arg levels in blood might be useful to evaluate the neurotoxic effects of NO generation. These findings might be helpful to guide future neuroprotective strategies in patients with ischemic stroke.
引用
收藏
页码:978 / 984
页数:7
相关论文
共 30 条
[1]   GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE - A STATEMENT FOR HEALTH-CARE PROFESSIONALS FROM A SPECIAL WRITING GROUP OF THE STROKE-COUNCIL, AMERICAN-HEART-ASSOCIATION [J].
ADAMS, HP ;
BROTT, TG ;
CROWELL, RM ;
FURLAN, AJ ;
GOMEZ, CR ;
GROTTA, J ;
HELGASON, CM ;
MARLER, JR ;
WOOLSON, RF ;
ZIVIN, JA ;
FEINBERG, W ;
MAYBERG, M .
STROKE, 1994, 25 (09) :1901-1914
[2]   Protective effect of N-(3-(aminomethyl benzyl) acetamidine, an inducible nitric oxide synthase inhibitor, in brain slices exposed to oxygen-glucose deprivation [J].
Cárdenas, A ;
De Alba, J ;
Moro, MA ;
Leza, JC ;
Lorenzo, P ;
Lizasoain, I .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 354 (2-3) :161-165
[3]   Nitric oxide-related brain damage in acute ischemic stroke [J].
Castillo, J ;
Rama, R ;
Dávalos, A .
STROKE, 2000, 31 (04) :852-857
[4]   Progression of ischaemic stroke and excitotoxic aminoacids [J].
Castillo, J ;
Davalos, A ;
Noya, M .
LANCET, 1997, 349 (9045) :79-83
[5]   Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke [J].
Castillo, J ;
Davalos, A ;
Naveiro, J ;
Noya, M .
STROKE, 1996, 27 (06) :1060-1065
[6]   Body iron stores and early neurologic deterioration in acute cerebral infarction [J].
Dávalos, A ;
Castillo, J ;
Marrugat, J ;
Fernandez-Real, JM ;
Armengou, A ;
Cacabelos, P ;
Rama, R .
NEUROLOGY, 2000, 54 (08) :1568-1574
[7]   DETERIORATING ISCHEMIC STROKE - RISK-FACTORS AND PROGNOSIS [J].
DAVALOS, A ;
CENDRA, E ;
TERUEL, J ;
MARTINEZ, M ;
GENIS, D .
NEUROLOGY, 1990, 40 (12) :1865-1869
[8]  
DELZOPPO GJ, 1994, CEREBROVAS BRAIN MET, V6, P47
[9]   1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo [J].
Garvey, EP ;
Oplinger, JA ;
Furfine, ES ;
Kiff, RJ ;
Laszlo, F ;
Whittle, BJR ;
Knowles, RG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (08) :4959-4963
[10]   RECENT INFECTION AS A RISK FACTOR FOR CEREBROVASCULAR ISCHEMIA [J].
GRAU, AJ ;
BUGGLE, F ;
HEINDL, S ;
STEICHENWIEHN, C ;
BANERJEE, T ;
MAIWALD, M ;
ROHLFS, M ;
SUHR, H ;
FIEHN, W ;
BECHER, H ;
HACKE, W .
STROKE, 1995, 26 (03) :373-379